Connection

Julian Schulze Zur Wiesch to HIV Integrase Inhibitors

This is a "connection" page, showing publications Julian Schulze Zur Wiesch has written about HIV Integrase Inhibitors.
  1. Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients. Medicine (Baltimore). 2019 Aug; 98(32):e16721.
    View in: PubMed
    Score: 0.687
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.